Literature DB >> 27418831

Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China.

Rong Zeng1, Tao Shou2, Kun-Xian Yang3, Tao Shen4, Jin-Ping Zhang4, Rong-Xia Zuo4, Yong-Qing Zheng4, Xin-Ming Yan4.   

Abstract

OBJECTIVE: This study investigated clinical and pathological characteristics and risk factors in papillary thyroid carcinoma (PTC) patients' native to Yunnan plateau in southwestern China.
METHODS: Clinical data from 1,198 patients diagnosed with PTC (n=578) and control subjects (n=620) with benign thyroid disease (ie, thyroid nodule disease, benign thyroid diseases [BTD]) in Yunnan province were analyzed retrospectively.
RESULTS: The mean patient age was lower for PTC than for BTD. Positive ratios of thyroid peroxidase antibody, thyroglobulin antibody (TGAb), and thyrotrophin receptor antibody (TRAb) were higher in PTC than in BTD patients. The ratio of PTC coexisting with Hashimoto's thyroiditis (HT) or with lymphocytic thyroiditis was higher than that of BTD. The number of patients whose age at menarche was ≤13 years, who had given birth to less than or equal to two children, or who were in premenopause were higher in the PTC than in the BTD group. Multivariate conditional logistic regression analyses revealed that age >45 years, nodal size >1 cm, and elevated TG levels were protective factors against PTC. Abnormally elevated TGAb and TRAb levels were independent risk factors for PTC in females.
CONCLUSION: HT was not an independent risk factor for but was associated with PTC. TRAb is a risk factor for PTC in individuals living in the Yunnan plateau, but not for those in the plains region.

Entities:  

Keywords:  Yunnan plateau; autoimmune disease status; benign thyroid disease; papillary thyroid carcinoma; risk factors

Year:  2016        PMID: 27418831      PMCID: PMC4935083          DOI: 10.2147/TCRM.S105023

Source DB:  PubMed          Journal:  Ther Clin Risk Manag        ISSN: 1176-6336            Impact factor:   2.423


  66 in total

1.  Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland.

Authors:  M E DAILEY; S LINDSAY; R SKAHEN
Journal:  AMA Arch Surg       Date:  1955-02

Review 2.  Aviation, high altitude, cumulative radiation exposure and their associations with cancer.

Authors:  L S Krain
Journal:  Med Hypotheses       Date:  1991-01       Impact factor: 1.538

3.  The Neutrophil-to-Lymphocyte Ratio Correlates with Age in Patients with Papillary Thyroid Carcinoma.

Authors:  Jifeng Liu; Jintao Du; Jinchuan Fan; Kun Liu; Bing Zhang; Shaoxin Wang; Wei Wang; Zhaohui Wang; Yongcong Cai; Chunhua Li; Tao Yu; Guiquan Zhu; Jin Chen; Chao Li
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2015-04-15       Impact factor: 1.538

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Concurrent Medullary, Papillary, and Follicular Thyroid Carcinomas and Simultaneous Cushing's Syndrome.

Authors:  Haggi Mazeh; Amir Orlev; Ido Mizrahi; David J Gross; Herbert R Freund
Journal:  Eur Thyroid J       Date:  2014-11-22

6.  [Time trends and pathological characteristics of thyroid cancer in urban Beijing, 1995 - 2010].

Authors:  Lei Yang; Ting-ting Sun; Yan-nan Yuan; Ning Wang
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2013-02

Review 7.  Global iodine nutrition: Where do we stand in 2013?

Authors:  Elizabeth N Pearce; Maria Andersson; Michael B Zimmermann
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

8.  Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study.

Authors:  Pauline Brindel; Françoise Doyon; Frédérique Rachédi; Jean-Louis Boissin; Joseph Sebbag; Larrys Shan; Vaiana Chungue; Laure Yen Kai Sun; Frédérique Bost-Bezeaud; Patrice Petitdidier; John Paoaafaite; Joseph Teuri; Florent de Vathaire
Journal:  Am J Epidemiol       Date:  2007-10-26       Impact factor: 4.897

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.

Authors:  Ling Zhang; Hui Li; Qing-hai Ji; Yong-xue Zhu; Zhuo-ying Wang; Yu Wang; Cai-ping Huang; Qiang Shen; Duan-shu Li; Yi Wu
Journal:  BMC Cancer       Date:  2012-12-21       Impact factor: 4.430

View more
  4 in total

1.  The characteristics and risk factors of central compartment lymph node metastasis in cN0 papillary thyroid carcinoma coexistent with Hashimoto's thyroiditis.

Authors:  Kai Jin; Liang Li; Yahang Liu; Xudong Wang
Journal:  Gland Surg       Date:  2020-12

2.  Associations between Hashimoto Thyroiditis and Clinical Outcomes of Papillary Thyroid Cancer: A Meta-Analysis of Observational Studies.

Authors:  Shinje Moon; Hye Soo Chung; Jae Myung Yu; Hyung Joon Yoo; Jung Hwan Park; Dong Sun Kim; Young Joo Park
Journal:  Endocrinol Metab (Seoul)       Date:  2018-12

3.  Hashimoto's Thyroiditis: A "Double-Edged Sword" in Thyroid Carcinoma.

Authors:  Jiangyue Xu; Ke Ding; Lan Mu; Jiangsheng Huang; Fei Ye; Yu Peng; Can Guo; Chutong Ren
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

4.  FoxP3 promotes lymph node metastasis in patients with papillary thyroid carcinoma complicated with Hashimoto's thyroiditis.

Authors:  Rong Zeng; Yi Lyu; Heng Niu; Kunxian Yang; Xinmin Yan
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.